Pharmacovigilance – News and Features

Company’s Phase III program will be the last phase of testing before it seeks full approval for Crohn’s Disease.

Caliper combines in vitro and in vivo services of Novascreen Biosciences and Xenogen Biosciences to form Discovery Alliances & Services.

This evidence report is the first step in the two-step process of the Centers for Disease Control and Prevention's Evaluation of Genomic Applications in Practice and Prevention pilot project.

The project lead by Iongate involves quantitative analysis that can facilitate the description of dynamic processes in living systems.

Vanderbilt University Medical Center and the National Foundation for Cancer Research have established a cancer research center from $1 million funded by NFCR.

Researchers found that the more T-regulatory cells and the fewer T-cell lymphocytes present in the tumors of treated patients, the greater the likelihood the cancer would recur.

Serono will use Genedata’s computational solution to combine results from HCS assays with chemical and pharmacological information to identify promising drug candidates.

A multidisciplinary Purdue research team will lead one of eight national nanomedicine development centers.

ReNeuron files IND application to commence human clinical studies with ReN001 stem cell therapy for stroke.

InnoMed PredTox is a joint industry, academic and European Commission collaboration to improve drug safety testing.